Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CFO Scott Burrows sold 7,500 shares of the company’s stock in a transaction dated Monday, August 3rd. Spyre Therapeutics Price PerformanceSpyre Therapeutics stock traded down $0.59 during trading hours on Wednesday, hitting $104.35. Spyre Therapeutics, Inc. has a one year low of $14.51 and a one year high of $108.14. Get Spyre Therapeutics alerts:Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. Featured StoriesReceive News & Ratings for Spyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.